PMDIY (Pro Medicus) Other Financing: $-5.6 Mil (TTM As of Dec. 2025)


PMDIY Pro Medicus Ltd PMDIY
77 GF Score
Price $24.45
GF Value $31.72
Valuation Modestly Undervalued
! 1 Warning Sign
View Full Analysis

What is Pro Medicus Other Financing?

Pro Medicus PMDIY 77 Other Financing is $-5.6 Mil as of Dec. 2025. GuruFocus rates PMDIY with a GF Score™ of 77/100 and a GF Value™ of $31.72 (Modestly Undervalued). The stock has 1 warning sign investors should review.

Pro Medicus's Other Financing for the six months ended in Dec. 2025 was $-0.2 Mil.

Pro Medicus's Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 was $-5.6 Mil.

Pro Medicus Other Financing Historical Data

* Premium members only.

The historical data trend for Pro Medicus's Other Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pro Medicus Other Financing Chart

Pro Medicus Annual Data
Trend Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Other Financing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.38 -0.36 -0.39 -0.34 -0.42

Pro Medicus Semi-Annual Data
Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.19 -2.00 -0.16 -5.38 -0.23
PMDIY
77GF Score
Pro Medicus Ltd PMDIY
Other Financing is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Pro Medicus Other Financing Calculation

Other Financing represents other cash flow from financing activity that not otherwise classified, which includes:
Proceeds From Stock Option Exercised
Other Financing Charges

Other Financing for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $-5.6 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Other Financing →
What does a Other Financing of $-5.6 Mil mean?
Pro Medicus (PMDIY) has a Other Financing of $-5.6 Mil as of Dec. 2025. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Pro Medicus and its competitors.
Is Pro Medicus' Other Financing too high?
Pro Medicus' current Other Financing is $-5.6 Mil. Overall, Pro Medicus has a GF Score™ of 77/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Pro Medicus' Other Financing compare to VEEV and BTSG?
Pro Medicus' Other Financing of $-5.6 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Financing for a Healthcare Providers & Services company?
A good Other Financing depends on the Healthcare Providers & Services industry context. However, Other Financing should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Financing mean?
A high Other Financing can signal that a stock is expensive relative to its fundamentals. Other Financing represents other cash flow from financing activity that not otherwise classified. View historical data for Pro Medicus and its competitors. Pro Medicus's current Other Financing is $-5.6 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Pro Medicus stock overvalued right now?
Based on GuruFocus' analysis, Pro Medicus (PMDIY) is currently considered Modestly Undervalued. The stock's GF Value™ is $31.72, compared to a current price of $24.45 — trading 22.9% below its estimated fair value. The current Other Financing is $-5.6 Mil. Pro Medicus' overall GF Score™ is 77/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Financing calculated?
Other Financing is calculated from a company's financial statements. For Pro Medicus (PMDIY), the current Other Financing is $-5.6 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Pro Medicus (PMDIY) Overvalued in 2026?

Based on GuruFocus' analysis, Pro Medicus stock appears to be undervalued. The current stock price of $24.45 is trading 22.9% below its estimated GF Value™ of $31.72. GuruFocus considers Pro Medicus to be Modestly Undervalued.

Key valuation signals for PMDIY:

  • Other Financing: $-5.6 Mil
  • GF Value™: $31.72 vs. price of $24.45 (22.9% below fair value)
  • GF Score™: 77/100 with 1 warning sign

No single metric tells the full story. See the PMDIY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Pro Medicus Business Description

Address 450 Swan Street, Richmond, VIC, AUS, 3121
Pro Medicus is a healthcare IT company specializing in radiology imaging software. Its main product, Visage 7, is a clinical desktop application that radiologists use to view, enhance, and manipulate images from any device and make a diagnosis. Its main customers are US private academic hospitals. In fiscal 2025, Pro Medicus earned 90% of revenue in North America, 8% from Australia, and the remaining 2% in Europe.
77GF Score

Get the complete analysis for PMDIY

Other Financing is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$24.45
Price
$31.72
GF Value